Global Neuroendocrine Tumors (NET) Market Spotlight 2019 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 4, 2019--
The “Market Spotlight: Neuroendocrine tumors (NET)” report has been added to ResearchAndMarkets.com’s offering.
This Market Spotlight report covers the Neuroendocrine Tumors market, comprising key marketed and pipeline drugs, recent events and analyst opinion, clinical trials, probability of success, upcoming and regulatory events, patent information, a 10-year disease incidence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
Key Topics Covered:
RECENT EVENTS AND ANALYST OPINION
KEY UPCOMING EVENTS
KEY REGULATORY EVENTS
PROBABILITY OF SUCCESS
LICENSING AND ASSET ACQUISITION DEALS
CLINICAL TRIAL LANDSCAPE
Sponsors by status
For more information about this report visit https://www.researchandmarkets.com/r/pn9cf
View source version on businesswire.com:https://www.businesswire.com/news/home/20191104005377/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 11/04/2019 05:53 AM/DISC: 11/04/2019 05:53 AM